Dermatology · Salt Lake City, UT
NPI
1043316300
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
50 N Medical Dr
Salt Lake City, UT, 84132
Phone (801) 581-2955
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
19,355 services
Medicare patients, 2024
352
Average age 74
Drug cost, 2024
$1.0M
974 prescriptions
Company payments, 2024
$54.32
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas L Powell was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 12,200 times for 40 patients. In total Douglas L Powell billed 19,355 services in 57 codes, and Medicare paid $114K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-21.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 12,200 | 40 | $1.33 | $16K |
| 95044 Test - Miscellaneous | Office | 4,931 | 43 | $3.77 | $19K |
| 17003 Destruction Skin Lesion | Office | 657 | 112 | $4.86 | $3,193 |
| 95004 Test - Miscellaneous | Office | 301 | 24 | $2.84 | $856 |
| 99213 Office E&M - Established | Office | 245 | 172 | $64.53 | $16K |
| 99214 Office E&M - Established | Office | 218 | 153 | $88.69 | $19K |
| 17000 Destruction Skin Lesion | Office | 186 | 135 | $40.54 | $7,541 |
| 96900 Skin | Office | 96 | 21 | $17.89 | $1,717 |
| 96567 Skin | Office | 67 | 44 | $99.48 | $6,665 |
| 11102 Skin Biopsy | Office | 55 | 46 | $67.49 | $3,712 |
| 36415 Venipuncture Blood Collection | Office | 41 | 23 | $8.65 | $355 |
| 85025 Blood Count | Office | 36 | 21 | $7.61 | $274 |
| 80053 Clinical Chemistry | Office | 31 | 16 | $10.35 | $321 |
| 99203 Office E&M - New | Office | 29 | 29 | $78.12 | $2,265 |
| 17110 Destruction Skin Lesion | Office | 27 | 24 | $82.45 | $2,226 |
By year: 2022 $85K for 8,839 services; 2023 $102K for 14,237 services; 2024 $114K for 19,355 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 41 | 23 | $8.65 | $355 |
| 85025 Blood Count | 36 | 21 | $7.61 | $274 |
| 80053 Clinical Chemistry | 31 | 16 | $10.35 | $321 |
Medicare prescription drug claims, 2024
In 2024, the drug Douglas L Powell prescribed most often to Medicare patients was Triamcinolone Acetonide, with 105 prescriptions and refills. In total Douglas L Powell wrote 974 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 105 | 164 | 76 | $1,702 |
| Dupixent Syringe Dupilumab | 94 | 99 | 15 | $394K |
| Clobetasol Propionate Generic | 63 | 72 | 41 | $2,188 |
| Tacrolimus Generic | 55 | 70 | 41 | $8,089 |
| Dupixent Pen Dupilumab | 49 | 51 | Under 11 | $190K |
| Xolair Omalizumab | 39 | 39 | Under 11 | $137K |
| Fluconazole Generic | 37 | 48 | 12 | $640 |
| Ketoconazole Generic | 30 | 35 | 23 | $506 |
| Clindamycin Phosphate Generic | 28 | 36 | 22 | $741 |
| Doxycycline Hyclate Generic | 27 | 32 | Under 11 | $521 |
| Mycophenolate Mofetil Generic | 21 | 22 | Under 11 | $1,504 |
| Methotrexate Methotrexate Sodium | 21 | 28 | Under 11 | $195 |
| Minocycline Hcl Generic | 21 | 21 | Under 11 | $344 |
| Prednisone Generic | 21 | 27 | 15 | $78.09 |
| Desonide Generic | 21 | 22 | 21 | $885 |
Brand drugs: 250 claims; generic drugs: 724 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Douglas L Powell $54.32 ($54.32 in general payments such as food, travel and fees) from 2 companies. The largest payer was LEO Pharma Inc. with $41.07.
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 1 | $41.07 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $13.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.